| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |